{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-022572","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.533349+00:00","generated_at":"2026-05-15T22:15:03.219083+00:00","sec_items":["2.02","2.05","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Theravance Biopharma Phase 3 CYPRESS study fails; plans 50% workforce cut and strategic review","bullets":["Phase 3 CYPRESS study of ampreloxetine for nOH in MSA did not meet primary endpoint (OHSA composite); program halted.","Organizational restructuring to reduce cost base ~60% (~$70M) and impact ~50% of workforce; R&D wound down, G&A cut ~50%.","Board's Strategic Review Committee accelerating evaluation of alternatives including a sale of the company.","Preliminary cash $326.5M at Q4 2025; expected ~$400M at Q1 2026 after $25M YUPELRI and $50M TRELEGY milestones received.","YUPELRI FY2025 net sales $266.6M (+12% YoY); company expects ~$60-70M annualized cash flow from restructuring and YUPELRI."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-022572","json":"https://secwatch.observer/filing/0001104659-26-022572.json","markdown":"https://secwatch.observer/filing/0001104659-26-022572.md","text":"https://secwatch.observer/filing/0001104659-26-022572.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/tm267846d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:15:03.219083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9246ac14ae0aaac8a8523e6076bc8c927fb1ee5","claim":"Theravance Biopharma, Inc. announced a restructuring with charges of approximately $5 million to $7 million affecting R&D and G&A functions (approximately 50% of the Company’s overall workforce).","evidence_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001315257-26-000036","ticker":"KOP","company_name":"Koppers Holdings Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Koppers conditionally plans to shut Stickney, IL chemical operations; Q1 adjusted EPS down 19.7%","event_type":"other_material","sec_items":["2.02","2.05","5.02","5.07","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001315257-26-000036","json":"https://secwatch.observer/filing/0001315257-26-000036.json","markdown":"https://secwatch.observer/filing/0001315257-26-000036.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/0001315257-26-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/kop-20260507.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"potentially appropriate uses for the Stickney facility following the end of production activities. The Company expects this action to result in pre-tax charges to earnings of $227 million to $262 million through the end of 2029, approximately $170 million to $195 million of which constitutes non-cash charges and approximately $57 million to $67 million of which","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/0001315257-26-000036-index.htm"}},{"accession":"0001477333-26-000033","ticker":"NET","company_name":"Cloudflare, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Cloudflare Q1 revenue $639.8M +34% YoY; announces 20% workforce reduction","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001477333-26-000033","json":"https://secwatch.observer/filing/0001477333-26-000033.json","markdown":"https://secwatch.observer/filing/0001477333-26-000033.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/0001477333-26-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/cloud-20260507.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"On May 7, 2026, the Company announced a plan (the “Plan”) designed to further accelerate its evolution to an agentic AI-first operating model. As part of the Plan, the Company expects to reduce its current workforce by approximately 20%. The Company currently estimates that it will incur charges of between $140 million and $150 million in connection with the Plan","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/0001477333-26-000033-index.htm"}},{"accession":"0001104659-26-049837","ticker":"IAC","company_name":"IAC Inc.","filed_at":"2026-04-28T23:59:59+00:00","headline":"IAC announces name change to 'People Incorporated', restructuring with $40M cost savings, and C-suite changes","event_type":"other_material","sec_items":["2.02","7.01","2.05","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-049837","json":"https://secwatch.observer/filing/0001104659-26-049837.json","markdown":"https://secwatch.observer/filing/0001104659-26-049837.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/tm2612831d1_8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"Ahead of its name change to \"People Incorporated\" which is expected to occur with the release of Q2 2026 earnings in August, the Company has initiated a plan to consolidate its corporate functions with those of its People Inc. business (\" People \"), through a reduction in workforce, technology integrations, and other cost-saving measures over the coming quarters (the \" Plan \"). The Plan is expected to generate annual run-rate cost savings of approximately $40 million. The Plan is expected to be completed by Q1 of 2027. The Company expects to incur approximately $14 million in severance and related expenses, $48 million in non-cash stock-based compensation expense and $0.5 million to $1 million in other costs related to the Plan.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm"}},{"accession":"0001193125-26-155861","ticker":"SNAP","company_name":"Snap Inc","filed_at":"2026-04-15T23:59:59+00:00","headline":"Snap reports Q1 rev ~$1.53B (+12% YoY), adj EBITDA ~$233M; cuts 16% of staff (~1,000 jobs)","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-155861","json":"https://secwatch.observer/filing/0001193125-26-155861.json","markdown":"https://secwatch.observer/filing/0001193125-26-155861.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/d36756d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"increased operational efficiencies to accelerate our path toward net-income profitability. As a result, we currently estimate that we will incur pre-tax charges in the range of $95 million to $130 million, primarily consisting of severance and related costs, contract termination costs, and other impairment charges, of which $75 million to $100 million are expected","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm"}},{"accession":"0001539497-26-000812","ticker":"BCAB","company_name":"BioAtla, Inc.","filed_at":"2026-03-02T23:59:59+00:00","headline":"BioAtla initiates strategic review, cuts 70% workforce; CFO replaced; cash ~$7.1M","event_type":"other_material","sec_items":["2.02","7.01","2.05","5.02","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-26-000812","json":"https://secwatch.observer/filing/0001539497-26-000812.json","markdown":"https://secwatch.observer/filing/0001539497-26-000812.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/n5620_8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm"}},{"accession":"0001171843-26-002302","ticker":"CRMT","company_name":"AMERICAS CARMART INC","filed_at":"2026-04-07T23:59:59+00:00","headline":"America's Car-Mart to close 42 stores (31% of total); non-cash impairment ~$14M due to capital constraints","event_type":"other_material","sec_items":["2.05","2.06","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-002302","json":"https://secwatch.observer/filing/0001171843-26-002302.json","markdown":"https://secwatch.observer/filing/0001171843-26-002302.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/799850/000117184326002302/0001171843-26-002302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799850/000117184326002302/f8k_040726.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/799850/000117184326002302/0001171843-26-002302-index.htm"}},{"accession":"0001213900-26-033878","ticker":"NDRA","company_name":"ENDRA Life Sciences Inc.","filed_at":"2026-03-25T23:59:59+00:00","headline":"ENDRA Life Sciences cuts staff, initiates strategic alternatives review; severance costs $51K","event_type":"other_material","sec_items":["2.05","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-033878","json":"https://secwatch.observer/filing/0001213900-26-033878.json","markdown":"https://secwatch.observer/filing/0001213900-26-033878.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026033878/0001213900-26-033878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026033878/ea0283331-8k_endra.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"on March 19, 2026, the Company reduced the number of its employees in order to reduce cash expenditures and extend its operational runway. As a result, the Company expects to incur pre-tax cash charges of approximately $51,000 associated with severance payments to former employees.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026033878/0001213900-26-033878-index.htm"}},{"accession":"0001650372-26-000021","ticker":"TEAM","company_name":"Atlassian Corp","filed_at":"2026-03-11T23:59:59+00:00","headline":"Atlassian to cut ~10% workforce (~1,600 roles); CTO Rajeev Rajan departing","event_type":"other_material","sec_items":["2.05","7.01","5.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001650372-26-000021","json":"https://secwatch.observer/filing/0001650372-26-000021.json","markdown":"https://secwatch.observer/filing/0001650372-26-000021.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/0001650372-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/team-20260311.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","comparable_excerpt":"efficiency and sustainability. Position eliminations in each country are subject to local law and consultation requirements. The Company estimates it will incur approximately $225 million to $236 million in charges in connection with these actions, of which approximately $169 million to $174 million is expected to result in future cash outlays related to","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/0001650372-26-000021-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}